Vistin Pharma ASA (OSL:VISTN)

Vistin Pharma ASA Balance Sheet

Financials in millions NOK. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	22.04	16.42	12.8	26.2	1.44	35.75
Cash & Short-Term Investments	22.04	16.42	12.8	26.2	1.44	35.75
Cash Growth	549.28%	28.31%	-51.17%	1726.06%	-95.99%	-53.60%
Accounts Receivable	84.26	89.71	44.28	47.02	66.16	40.25
Other Receivables	15.99	10.43	7.7	12.56	5.01	2.85
Receivables	100.25	100.14	51.97	59.59	71.17	43.09
Inventory	70.49	82.13	76.67	80.17	83.45	42.91
Prepaid Expenses	-	4.83	1.75	2.81	3.14	16.09
Other Current Assets	-0	0	-	-	-	-
Total Current Assets	192.78	203.52	143.19	168.77	159.18	137.83
Property, Plant & Equipment	216.8	223.75	229.6	219.98	219.43	167.46
Long-Term Investments	12.15	12.15	12.15	-	-	-
Long-Term Deferred Tax Assets	-	-	-	14.64	28.6	27.86
Other Long-Term Assets	0	-	0	-	-	0
Total Assets	421.74	439.43	384.95	403.4	407.21	333.15

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	18.15	30.24	13.05	18.92	25.91	20.81
Accrued Expenses	-	14.82	15.82	16.59	14.67	16.58
Short-Term Debt	-	-	-	-	45.14	-
Current Portion of Leases	-	0.89	0.92	-	1.07	0.88
Current Income Taxes Payable	-	7.73	-	-	-	-
Other Current Liabilities	36.64	33.04	34.18	33.96	30.78	2.78
Total Current Liabilities	54.79	86.72	63.97	69.47	117.57	41.04
Long-Term Leases	0.03	0.62	1.33	-	2.96	0.51
Pension & Post-Retirement Benefits	6.09	6.42	6.6	8.86	13.2	15.83
Long-Term Deferred Tax Liabilities	29.78	16.86	3.52	-	-	-
Other Long-Term Liabilities	0	0	0	2.29	-0	0
Total Liabilities	90.69	110.62	75.42	80.63	133.73	57.38

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	44.35	44.35	44.35	44.35	44.35	44.35
Additional Paid-In Capital	29.52	73.87	129.3	206.89	206.89	206.89
Retained Earnings	257.18	210.6	135.89	71.54	22.26	24.54
Comprehensive Income & Other	0	-	-	-	-	-
Shareholders' Equity	331.04	328.81	309.53	322.77	273.49	275.77
Total Liabilities & Equity	421.74	439.43	384.95	403.4	407.21	333.15

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	0.03	1.51	2.24	-	49.17	1.39
Net Cash (Debt)	22.02	14.91	10.55	26.2	-47.73	34.36
Net Cash Growth	-	41.28%	-59.73%	-	-	-55.40%
Net Cash Per Share	0.50	0.34	0.24	0.59	-1.08	0.77
Filing Date Shares Outstanding	44.34	44.34	44.34	44.34	44.34	44.34
Total Common Shares Outstanding	44.34	44.34	44.34	44.34	44.34	44.34
Working Capital	137.99	116.8	79.22	99.3	41.61	96.8
Book Value Per Share	7.47	7.41	6.98	7.28	6.17	6.22
Tangible Book Value	331.04	328.81	309.53	322.77	273.49	275.77
Tangible Book Value Per Share	7.47	7.41	6.98	7.28	6.17	6.22
Machinery	-	281.31	268.64	263.53	253.37	-
Construction In Progress	-	39.32	39.09	17.91	10.24	-

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error